Cargando…
Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey
AIM: This review summarizes current data on Rho-kinase (ROCK) inhibitors use in ocular diseases, primarily glaucoma. BACKGROUND: Translational research over the last decade culminating in the development of ROCK inhibitors has provided a much-needed shot in the arm to glaucoma pharmacopeia. ROCK pat...
Autores principales: | Singh, Kirti, Singh, Arshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203326/ https://www.ncbi.nlm.nih.gov/pubmed/37228304 http://dx.doi.org/10.5005/jp-journals-10078-1396 |
Ejemplares similares
-
Ocular hypotensive effects of a Rho-associated protein kinase inhibitor in rabbits
por: Kamaruddin, Muhammad Irfan, et al.
Publicado: (2017) -
Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
por: Al-Humimat, Ghadeer, et al.
Publicado: (2021) -
Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
por: Okumura, Naoki, et al.
Publicado: (2017) -
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases
por: Wang, Qing, et al.
Publicado: (2022) -
Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors
por: Olson, Michael F.
Publicado: (2016)